Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Find the most relevant tenders for Currency Vending Or Dispenser Machinecashnotechequecoin. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Currency Vending Or Dispenser Machinecashnotechequecoin tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Currency Vending Or Dispenser Machinecashnotechequecoin tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lisdexamfetamine Atc N06Ba12 Obg For The Period 01 08 24 31 07 25 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6367992

EMD:Ref Document

Bid Value: Ref Document

206 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Omalizumab Atc R03Dx05 Obo For The Period 01 08 2024 31 07 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6344888

EMD:Ref Document

Bid Value: Ref Document

206 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Colistin Atc J01Xb01 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6340118

EMD:Ref Document

Bid Value: Ref Document

206 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Albendazole Atc P02Ca03 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6337365

EMD:Ref Document

Bid Value: Ref Document

206 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Pomalidomide Atc L04Ax06 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6335525

EMD:Ref Document

Bid Value: Ref Document

206 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Oralair Atc Code According To Who V01Aa02

Deadline: 31 Jul 2026

Germany

Ref. No.: 6175344

EMD:Ref Document

Bid Value: Ref Document

262 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Lipegfilgrastim Atc Code According To Who L03Aa14

Deadline: 30 Apr 2026

Germany

Ref. No.: 6174040

EMD:Ref Document

Bid Value: Ref Document

170 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Orylmyte Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 6173952

EMD:Ref Document

Bid Value: Ref Document

262 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Itulazax Atc Code According To Who V01Aa05

Deadline: 31 Jul 2026

Germany

Ref. No.: 6171828

EMD:Ref Document

Bid Value: Ref Document

262 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Fentanyl In The Dosage Form Of Sublingual Tablets Atc Code According To Wh

Deadline: 30 Jun 2026

Germany

Ref. No.: 6165516

EMD:Ref Document

Bid Value: Ref Document

231 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 6108284

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epinephrine In The Dosage Form Ilo

Deadline: 10 May 2026

Germany

Ref. No.: 5978859

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Not Exclusive Of Am Discount Agreement According To Section 130A Paragraph 8 Sgb V By Means Of An Oh Model For Ws Epoetin Alfa Genetically Engineered Human Erythropoietin Restriction To Packs With Doses Up To 10 000 Iu

Deadline: 31 Jul 2026

Germany

Ref. No.: 5978748

EMD:Ref Document

Bid Value: Ref Document

262 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Filgrastim Atc Code According To Who L03Aa02

Deadline: 30 Jun 2026

Germany

Ref. No.: 5978377

EMD:Ref Document

Bid Value: Ref Document

231 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg And The Dosage Form Smt

Deadline: 10 May 2026

Germany

Ref. No.: 5978310

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Showing 2431 to 2445 of 2466 results

Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Filter Your Search

FREE Trial plan for all new users!